Drugs / imidazolylethylamide of pentanedioic acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06859333 | Jan → Dec 2025 overdue | influenza | Valenta Pharm JSC | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | imidazolylethylamide of pentanedioic acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06859333 ↗ |
| Route | Oral | “Multiple Oral Administration” NCT06859333 ↗ |